• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年上皮性卵巢癌患者行初次肿瘤细胞减灭术:手术结局与长期生存分析。

Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival.

机构信息

Department of Gynecology and Obstetrics, Campus Virchow Clinic, Charité University Hospital, Augustenburger Platz 1, 13353 Berlin, Germany.

出版信息

Int J Gynecol Cancer. 2010 Jan;20(1):34-40. doi: 10.1111/IGC.0b013e3181c10c04.

DOI:10.1111/IGC.0b013e3181c10c04
PMID:20130501
Abstract

OBJECTIVE

Geriatric population life expectancy is increasing and so is the incidence of epithelial ovarian cancer (EOC) in elderly women. The aim of our study was to determine the impact of radical cytoreductive surgery, the cornerstone of clinical management in primary EOC, in this population with special regard to the associated morbidity.

METHODS

Through a pooled data analysis, cancer-related patient characteristics, intraoperative tumor pattern, and surgical and clinical outcomes were evaluated according to a validated documentation data collection tool. Kaplan-Meier curves were calculated for overall survival (OS). The Cox regression analysis was performed to identify independent predictors of mortality.

RESULTS

One hundred one EOC patients older than 69 years (mean [SD] age, 75.54 [4.49] years) were evaluated. The mean (SD) follow-up period was 22.63 (22.92) months. Advanced International Federation of Gynecology and Obstetrics stage III (60.4%) was the most common tumor stage. A complete tumor resection was achieved in 45 patients (44.6%) with an associated complication rate of 40.6%. The postoperative mortality was 6%. The mean OS was 47.29 months (95% confidence interval, 36.24-58.34). The multivariate analysis identified age older than 75 years, incomplete tumor resection, and absence of adjuvant chemotherapy to negatively affect OS.

CONCLUSIONS

Radical surgery for primary EOC obtaining complete tumor resection is associated with a significantly prolonged OS in elderly patients (> or =70 years). The increased postoperative morbidity must be considered, underlining the high requirement for special interdisciplinary postoperative management in this special collective.

摘要

目的

老年人口的预期寿命在延长,老年女性上皮性卵巢癌(EOC)的发病率也在上升。我们研究的目的是确定根治性细胞减灭术的影响,这是原发性 EOC 临床管理的基石,特别是考虑到相关发病率。

方法

通过汇总数据分析,根据经过验证的文档数据收集工具评估癌症相关患者特征、术中肿瘤模式以及手术和临床结局。计算总生存期(OS)的 Kaplan-Meier 曲线。进行 Cox 回归分析以确定死亡率的独立预测因素。

结果

评估了 101 例年龄大于 69 岁(平均[SD]年龄,75.54 [4.49] 岁)的 EOC 患者。平均(SD)随访时间为 22.63(22.92)个月。国际妇产科联合会(FIGO)晚期 III 期(60.4%)是最常见的肿瘤分期。45 例患者(44.6%)实现了完全肿瘤切除,相关并发症发生率为 40.6%。术后死亡率为 6%。平均 OS 为 47.29 个月(95%置信区间,36.24-58.34)。多变量分析确定年龄大于 75 岁、不完全肿瘤切除和无辅助化疗是影响 OS 的负面因素。

结论

对原发性 EOC 进行根治性手术,获得完全肿瘤切除与老年患者(≥70 岁)显著延长的 OS 相关。必须考虑到术后发病率的增加,这突出了在这个特殊人群中对特殊的多学科术后管理的高要求。

相似文献

1
Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival.老年上皮性卵巢癌患者行初次肿瘤细胞减灭术:手术结局与长期生存分析。
Int J Gynecol Cancer. 2010 Jan;20(1):34-40. doi: 10.1111/IGC.0b013e3181c10c04.
2
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
5
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.上皮性卵巢癌国际妇产科联盟(FIGO)分期 IIA-IV 期患者残余肿瘤大小的预后价值:OVCAD 数据分析。
Int J Gynecol Cancer. 2012 Mar;22(3):380-5. doi: 10.1097/IGC.0b013e31823de6ae.
6
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.晚期上皮性卵巢癌初始治疗中,术前新辅助化疗与手术加化疗的比较。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub7.
7
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛性)手术与标准手术用于晚期上皮性卵巢癌的初次肿瘤细胞减灭术对比
Cochrane Database Syst Rev. 2011 Apr 13(4):CD007697. doi: 10.1002/14651858.CD007697.pub2.
8
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
9
The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India.完全细胞减灭术联合腹腔热灌注化疗在卵巢癌中的作用:我们如今处于什么阶段?来自印度一家领先肿瘤中心的全面综述与临床见解。
World J Surg Oncol. 2025 Jun 11;23(1):232. doi: 10.1186/s12957-025-03869-0.
10
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.用于治疗复发性上皮性卵巢癌的促黄体生成素释放激素(LHRH)激动剂。
Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD011322. doi: 10.1002/14651858.CD011322.pub2.

引用本文的文献

1
Pre-Operative Malnutrition in Patients with Ovarian Cancer: What Are the Clinical Implications? Results of a Prospective Study.卵巢癌患者的术前营养不良:临床意义是什么?一项前瞻性研究的结果
Cancers (Basel). 2024 Jan 31;16(3):622. doi: 10.3390/cancers16030622.
2
Total Colectomy as a Part of Ultra-Radical Surgery for Ovarian Cancer-Short- and Long-Term Outcomes.全结肠切除术在卵巢癌超根治性手术中的应用——短期和长期结局。
Curr Oncol. 2021 Oct 18;28(5):4223-4233. doi: 10.3390/curroncol28050358.
3
Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HR-QoL) in Patients with Ovarian Cancer: What Is Different Compared to Healthy Women?
卵巢癌患者的患者报告结局(PROs)和健康相关生活质量(HR-QoL):与健康女性相比有何不同?
Cancers (Basel). 2021 Feb 5;13(4):631. doi: 10.3390/cancers13040631.
4
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).妇科癌症患者在 COVID-19 大流行期间的观点、担忧和期望:欧洲妇科癌症倡导团体网络(ENGAGe)的泛欧研究。
Cancer Med. 2021 Jan;10(1):208-219. doi: 10.1002/cam4.3605. Epub 2020 Nov 18.
5
GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.老年卵巢癌患者治疗中的老年综合评估(GERSOC):一项实用、整群随机对照试验的研究方案。
Trials. 2020 Feb 22;21(1):214. doi: 10.1186/s13063-020-4157-y.
6
Impact of brief prewarming on anesthesia-related core-temperature drop, hemodynamics, microperfusion and postoperative ventilation in cytoreductive surgery of ovarian cancer: a randomized trial.简短预热对卵巢癌减瘤手术中麻醉相关核心体温下降、血流动力学、微灌注及术后通气的影响:一项随机试验
BMC Anesthesiol. 2019 Aug 22;19(1):161. doi: 10.1186/s12871-019-0828-1.
7
The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years.标准护理治疗在老年卵巢癌女性中的应用及结果:过去10年的文献综述
Front Oncol. 2016 Mar 24;6:63. doi: 10.3389/fonc.2016.00063. eCollection 2016.
8
Clinical significance of para-aortic lymph node dissection and prognosis in ovarian cancer.卵巢癌腹主动脉旁淋巴结清扫术的临床意义及预后
Front Med. 2014 Mar;8(1):96-100. doi: 10.1007/s11684-014-0316-4. Epub 2014 Jan 25.
9
Pelvic exenteration: impact of age on surgical and oncologic outcomes.盆腔廓清术:年龄对手术和肿瘤学结果的影响。
Gynecol Oncol. 2014 Jan;132(1):114-8. doi: 10.1016/j.ygyno.2013.11.014. Epub 2013 Nov 18.